Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape ; volume:39 ; number:1 ; day:30 ; month:11 ; year:2021 ; pages:148-164 ; date:1.2022
Advances in therapy ; 39, Heft 1 (30.11.2021), 148-164, 1.2022
- Urheber
-
Mende, Christian W.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-021-01994-2
- URN
-
urn:nbn:de:101:1-2022050720251438884172
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mende, Christian W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evolving insights into the pleiotropic cardioprotective mechanisms of SGLT2 inhibitors
Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study
SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
Direct cardiac effects of SGLT2 inhibitors
Divarasib in the Evolving Landscape of KRAS G12C Inhibitors for NSCLC
Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease?
MAPPING EVOLVING HISTORICAL LANDSCAPE SYSTEMS
SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease
SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere
Evolving insights into the pleiotropic cardioprotective mechanisms of SGLT2 inhibitors
Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study
SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
Direct cardiac effects of SGLT2 inhibitors
Divarasib in the Evolving Landscape of KRAS G12C Inhibitors for NSCLC
Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease?
MAPPING EVOLVING HISTORICAL LANDSCAPE SYSTEMS
SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease
SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere
Evolving insights into the pleiotropic cardioprotective mechanisms of SGLT2 inhibitors
Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study
SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
Direct cardiac effects of SGLT2 inhibitors
Divarasib in the Evolving Landscape of KRAS G12C Inhibitors for NSCLC
Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease?
MAPPING EVOLVING HISTORICAL LANDSCAPE SYSTEMS
SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease